U.S. 503B Compounding Pharmacies Market is Expected to be Flourished by Rising Demand for Customized Medications

 

U.S. 503B Compounding Pharmacies Market

The U.S. 503B compounding pharmacies market has witnessed significant growth in recent years due to the increasing need for personalized medications. 503B compounding pharmacies or outsourcing facilities are specialized pharmacies that are allowed to produce large volumes of medications strictly based on the receipt of a valid prescription for an individually identified patient. These pharmacies offer compounded medications which allow pharmacists to alter dosage form, flavors, delivery systems, potency, and other characteristics to meet patient-specific needs. This has led to rising demand for compounded medications for various therapeutic applications such as pain management, hormone replacement therapy, dermatology, and veterinary medicines.


The global U.S. 503B compounding pharmacies market is estimated to be valued at US$ 1060.51 billion in 2023 and is expected to exhibit a CAGR of 6.3% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

Market Dynamics
Rising demand for customized medications and focus on specialty medications are expected to drive the growth of the U.S. 503B compounding pharmacies market over the forecast period. 503B compounding pharmacies play a crucial role in fulfilling unmet medical needs by producing compounded formulations as prescribed by physicians when an FDA-approved drug may be unsuitable. This allows patients to receive individually tailored therapies specifically designed for their unique medical needs. The healthcare industry has also shifted its focus towards specialty medications in recent years owing to changing disease patterns and increasing emphasis on precision medicine. This, along with growing geriatric population prone to chronic diseases, supplements the demand for specialized and personalized compounded therapies, thereby supporting market growth.
Segment Analysis

The U.S. 503B compounding pharmacies market is dominated by the sterile and non-sterile segments. The sterile segment accounts for over 60% share as most of the drugs supplied by 503B compounding pharmacies require sterility. The demand for sterile drugs is high due to rising incidence of chronic diseases that require injections and intravenous therapies.

PEST Analysis

Political: The pharmaceutical industry is highly regulated in the US to ensure drug safety and efficacy. The FDA has issued the CGMP regulations in 2019 to strengthen the standards and oversight of 503B compounding pharmacies.

Economic: Rising healthcare spending in the US along with an aging population drives the demand for compounding drugs to meet specialized medical needs. The market size is expected to grow at 6.3% annually and reach US$ 1060.51 billion by 2023 supported by economic growth.

Social: Increasing incidence of chronic and lifestyle diseases has enhanced the need for tailored medication. 503B compounding pharmacies help meet the needs of patients who cannot use FDA-approved drugs due to allergies and intolerances.

Technological: 503B facilities utilize advanced technologies like clean rooms, laminar air-flow workbenches for sterility assurance and quality production in large volumes. Adoption of automated compounding systems has improved efficiency.

Key Takeaways

The U.S. 503B Compounding Pharmacies Market Share is expected to witness high growth due to rising demand for specialized medications that cannot be met through FDA-approved drugs. The sterile segment dominates owing to the large volume of injectable and intravenous therapies used for chronic diseases.

Regional analysis: The Western region currently accounts for over 45% market share led by states like California, Texas and Florida having high healthcare infrastructure and expenditure. The rising geriatric population in these states drives the demand for compounded drugs.

Key players: Key players operating in the U.S. 503B compounding pharmacies market are Merck & Co., Inc., Ferring Pharmaceuticals, Inc., EMD Serono, Inc., Pfizer Inc., Novartis AG. Merck & Co., Inc. is a market leader owing to its wide product portfolio and strong distribution network across the US.
For more details on the report, Read- https://www.pressreleasebulletin.com/u-s-503b-compounding-pharmacies-market-overview/

Comments

Post a Comment

Popular posts from this blog

The Notchback Market is Estimated To Witness High Growth Owing To Rising Demand From Emerging Economies

Image
  Notchback Market Market Overview: A notchback is a body style of cars characterized by a gently sloped rear window and greenhouse. Notchbacks provide practical interior space with good cargo capacity. They offer balanced interior volume for passengers and cargo along with sleek and stylish exterior design. The body style has advantages like no C-pillar which enhances visibility compared to sedans. Market key trends: The growth of the notchback market is attributed to rising demand from emerging economies like China, India and Brazil. These nations have growing middle-class population and increasing disposable income which is driving vehicle ownership. Moreover, notchback body style is quite popular in these developing markets due to its spacious cabin combined with stylish looks at affordable prices. Leading automakers are launching various notchback models to cater to the surging demand from developing countries, which is fueling the growth of the notchback market size during ...
Read more

The increasing demand for adhesives and sealants is anticipated to open up the new avenue for Petroleum Resins Market

Image
Petroleum Resins Market  Market Overview: Petroleum resins are amorphous thermoplastic polymers made from petroleum-based feedstock materials, through either thermal or catalytic polymerization. They are mainly used for applications such as adhesives, inks, paints, rubber compounding, and others. Different types of petroleum resins include C5 resins, C9 resins, hydrogenated hydrocarbons (HHCs), and modified and specialized petroleum resins. Among applications, adhesives and sealants hold the largest share in the petroleum resins market owing to increasing use of petroleum resins in hot melt and pressure sensitive adhesives. Market Dynamics: The increasing demand for adhesives from packaging and construction industries is a major driver for the petroleum resins market. According to statsista, the global adhesive market was valued at over US$ 53.3 billion in 2020 and is projected to reach around US$ 78 billion by 2027, growing at a CAGR of over 5.7% during the forecast period. Pe...
Read more

The global Biopharmaceuticals Market connected with therapeutic biologics

Image
Biopharmaceuticals Market Market Overview: The biopharmaceuticals market comprises medicines produced using biotechnology methods like genetic engineering and includes vaccines, blood components, recombinant therapeutic proteins/antibodies, and monoclonal antibodies. Biopharmaceuticals are often used for treating serious medical conditions like cancer, autoimmune diseases, and other chronic disorders. These drugs provide targeted treatment options and have lesser side effects than traditional small-molecule drugs. The market is witnessing high demand due to increasing prevalence of chronic diseases and growing geriatric population globally. Market key trends: One of the key trends gaining traction in The Biopharmaceuticals Market Demand is the increasing adoption of biosimilars. Biosimilars are quasi-generic versions of original biologics and provide more affordable treatment options when the patents of biologics expire. Regulatory agencies in various regions are also approving bios...
Read more